You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HPV Associated Malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cervical Cancer, HPV Cancers, Anal Cancer Trial run by the NCI (PDS0101, M7824, NHS-IL12)

Active, not recruiting
  • Cervical Cancer
  • +4 more
  • PDS0101
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 24, 2023

Human Papilloma Virus, Cervical Cancer, Oropharyngeal Cancer Trial run by the NCI (M7824)

Active, not recruiting
Has Results
  • Human Papilloma Virus
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 28, 2022

Cancer, Solid Tumor, Metastatic Checkpoint Refractory HPV Associated Malignancies Trial run by the National Cancer Institute

Recruiting
  • Cancer
  • +3 more
  • Bintrafusp Alfa
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 11, 2022

HPV 16+ Recurrent or Metastatic Cancer Trial (CD8 reduced peripheral blood cells taken from related donors vaccinated against

Not yet recruiting
  • HPV 16+ Recurrent or Metastatic Cancer
  • CD8 reduced peripheral blood cells taken from related donors vaccinated against HPV16
  • Non-myeloablative allogeneic bone marrow transplant from related donors vaccinated against HPV16
  • (no location specified)
Jun 27, 2022

HPV-associated Oropharyngeal Cancer

Recruiting
  • PREDICTIVE BIOMARKERS
  • +2 more
  • HPV-ASSOCIATED OROPHARYNGEAL CANCER
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Oct 19, 2023

HPV Associated Anogenital Pathology in Female Patients and

Recruiting
  • Oropharyngeal Human Papillomavirus-Positive Squamous Cell Carcinoma
  • Non-Interventional Study
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 2, 2023

Cervical Cancer, Head Neck Cancer, Anal Cancer Trial in United States (RTX-321)

Recruiting
  • Cervical Cancer
  • +2 more
  • Birmingham, Alabama
  • +9 more
Feb 7, 2022

Human Papillomavirus (HPV)-Related Malignancies, Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies

Completed
Has Results
  • Human Papillomavirus (HPV)-Related Malignancies
  • Recurrent/Metastatic (R/M) Human Papillomavirus (HPV)-Related Malignancies
  • Basking Ridge, New Jersey
  • +5 more
Dec 14, 2022

HPV-Related Carcinoma Trial (IBRX-042)

Not yet recruiting
  • HPV-Related Carcinoma
  • (no location specified)
Jul 26, 2023

Cervical Cancer, Throat Cancer, Oropharynx Cancer Trial in New Brunswick (E7 TCR-T cells)

Not yet recruiting
  • Cervical Cancer
  • +20 more
  • E7 TCR-T cells
  • New Brunswick, New Jersey
  • +1 more
Jan 18, 2023

HPV Associated Cancers Trial in New York, Houston (TGN-S11, Pembrolizumab)

Not yet recruiting
  • HPV Associated Cancers
  • New York, New York
  • +1 more
Apr 25, 2023

Oropharyngeal Squamous Cell Carcinoma (SCC) Trial run by the National Cancer Institute (NCI) (PRGN-2009, Pembrolizumab)

Not yet recruiting
  • Oropharyngeal Squamous Cell Carcinoma (SCC)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 22, 2023

Viral Associated Malignancies, Kaposi Sarcoma, EBV/KSHV-associated Lymphomas Trial run by the NCI (Pomalidomide, Nivolumab)

Recruiting
  • Viral Associated Malignancies
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 20, 2022

Cervical Cancer, Cervical Dysplasia, Oropharyngeal Cancer Trial in Olomouc (Arm A - Diagnostic test: HPV detection in liquid

Recruiting
  • Cervical Cancer
  • +3 more
  • Arm A - Diagnostic test: HPV detection in liquid biopsies
  • Arm B - Diagnostic test: HPV detection in liquid biopsies
  • Olomouc, Czechia
    University Hospital Olomouc
Mar 7, 2023

HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T

Not yet recruiting
  • HPV-Associated Cervical Carcinoma
  • +16 more
  • Conditioning, E7 TCR-T cells, and aldesleukin
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 17, 2023

Cervix Uteri SIL, HPV, CIN2 Trial in Prague (Colposcopy)

Recruiting
  • Cervix Uteri SIL
  • +3 more
  • Colposcopy
  • Prague, Czechia
    General University Hospital
Nov 24, 2023

Human Papillomavirus Viruses, Papillomavirus Vaccines Trial in Cincinnati (K-Talk Intervention (Storytelling and K-Bot),

Recruiting
  • Human Papillomavirus Viruses
  • Papillomavirus Vaccines
  • K-Talk Intervention (Storytelling and K-Bot)
  • +3 more
  • Cincinnati, Ohio
    Minjin Kim
May 31, 2023

Cancer, HPV Associated Cancer Trial (GLAm app)

Not yet recruiting
  • Cancer
  • HPV Associated Cancer
  • GLAm app
  • (no location specified)
Dec 27, 2022

Advanced Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Australia, United States (TransCon TLR7/8

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • Duarte, California
  • +12 more
Sep 21, 2022

Human Papillomavirus-Related Carcinoma Trial in Austria, United States (procedure, biological, other)

Not yet recruiting
  • Human Papillomavirus-Related Carcinoma
  • Biospecimen Collection
  • +4 more
  • Birmingham, Alabama
  • +4 more
Aug 9, 2023

Squamous Cell Carcinoma of Head and Neck Trial (Combination 5-azacytidine and nivolumab, 5-azacytidine, Nivolumab)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Combination 5-azacytidine and nivolumab
  • +2 more
  • (no location specified)
Dec 7, 2022

Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant

Active, not recruiting
  • Allogeneic Hematopoietic Stem Cell Transplant Recipient
  • Hematopoietic and Lymphoid Cell Neoplasm
  • Recombinant Human Papillomavirus Nonavalent Vaccine
  • Houston, Texas
    M D Anderson Cancer Center
Jun 29, 2022

Gynecologic Tumor, Brachytherapy, Therapeutic Touch Trial in Salt Lake City (Reiki therapy)

Not yet recruiting
  • Gynecologic Neoplasm
  • +6 more
  • Reiki therapy
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Aug 9, 2023

Recurrent Human Papillomavirus Type 16 Associated Cancer Trial in Birmingham, Baltimore (HPV 16 TA-CIN)

Withdrawn
  • Recurrent Human Papillomavirus Type 16 Associated Cancer
  • HPV 16 TA-CIN
  • Birmingham, Alabama
  • +1 more
Nov 29, 2022

Squamous Cell Carcinoma Trial in New York (Standard surveillance, Telemedicine surveillance (tele-surveillance), Questionnaires)

Recruiting
  • Squamous Cell Carcinoma
  • Standard surveillance
  • +2 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center (All Protocol Activities)
Aug 17, 2022